HEAL Commercialization Readiness Pilot (CRP) Program
Department of Health and Human Services (NIH)
Total funding support up to $400,000
Maximum project period of 2 years
Facilitate the transition of SBIR and STTR Phase II and Phase IIB projects in pain management to commercialization.
Support the addition of entrepreneurial expertise into small business leadership teams.
Small Business Concerns (SBCs) focused on pain management technologies.
NIH funding through the HEAL Initiative.
Grant funding mechanism.
Addresses the opioid crisis by promoting non-addictive pain management solutions.
Recurring funding opportunity with multiple application deadlines.
U.S. small business concerns (SBCs) that have received NIH SBIR or STTR Phase II or Phase IIB funding.
Must have received an active NIH SBIR or STTR Phase II or Phase IIB award within the last 36 months.
Organizations must be based in the United States.
Applicants must demonstrate a need for private partnership to achieve commercialization.
SBCs must have no more than 500 employees.
Not specified.
Not specified.
Pain management technologies and therapies.
Small businesses in the healthcare sector focused on pain management.
Successful commercialization of pain management technologies.
Not specified.
Expertise in business development and fundraising.
Must include a business development expert at a minimum of 50% effort.
Total funding support up to $400,000, with no more than $200,000 per year.
Funding may only support labor costs affiliated with proposed activities.
Applications due by 5:00 PM local time on specified due dates.
Milestones include hiring a business development expert and meeting with potential partners.
Must comply with NIH Grants Policy Statement.
Application must include a detailed hiring plan and partnering plan.
Applications will be evaluated based on the likelihood of successful commercialization.